RBC Capital Downgrades Amrize to Underperform, Lowers Price Target to $48

Benzinga Newsdesk www.benzinga.com Negative 90.5%

Neg 90.5% Neu 0% Pos 0%

RBC Capital analyst Anthony Codling downgrades Amrize (NYSE:AMRZ) from Sector Perform to Underperform and lowers the price target from $60 to $48.